EVP, Global Infrastructure and Operations. Power of Attorney

President, Research & Development Solutions Power of Attorney

President, MedTech and Consumer Health Power of Attorney

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Institution	Shares	Value	Change
Vanguard	20,152,585	$3.9B	DECREASED
BlackRock	14,549,693	$2.8B	DECREASED
Harris Associates L P	12,183,830	$2.4B	INCREASED
State Street	7,508,244	$1.5B	INCREASED
JPMorgan Chase	6,139,775	$1.2B	INCREASED

Insider	Type	Shares	Value	Date
James G. Berkshire (EVP, Global Infrastructure and Operations. Power of Attorney)	SELL	2,713	$710K	2026-09-02
James G. Berkshire (EVP, Global Infrastructure and Operations. Power of Attorney)	EXERCISE	5,381	$709K	2026-09-02
James G. Berkshire (EVP, Global Infrastructure and Operations. Power of Attorney)	SELL	2,668	$697K	2026-09-02
Richard W Staub (President, Research & Development Solutions Power of Attorney)	SELL	5,500	$1M	2026-08-03
Bhavik Patel (President, MedTech and Consumer Health Power of Attorney)	SELL	1,855	$436K	2026-07-31

IQVIA Holdings Inc. (IQV) Ownership & Trading Activity

Top Institutional Holders

Recent Insider Trades